HB 22-1116 CO

0likes☆Favorite🔕SubscribeShare

Introduced

The bill creates the plant-based medicine policy review panel (policy review panel). The purpose of the policy review panel is to study the use of plant-based medicines to support mental health. The policy review panel operates for one year. The policy review panel shall submit a report on its findings and policy recommendations to the house of representatives public and behavioral health and human services committee and the senate health and human services committee, or any successor committees; the governor; and the department of human services. The bill defines "plant-based medicine" as a naturally occurring hallucinogenic plant-based compound. Forms of plant-based medicine only include psilocybin, psilocyn, dimethyltryptamine, and ibogaine. (Note: This summary applies to this bill as introduced.)

• Alex Valdez Democratic · primary
• Joann Ginal · primary

1. Apr 5, 2022 House Committee on Public & Behavioral Health & Human Services Postpone Indefinitely · lower
2. Jan 21, 2022 Introduced In House - Assigned to Public & Behavioral Health & Human Services · lower

The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.

• Introduced (01/21/2022) · PDF
• Committee Amendment · PDF